Skip to content
Search

Latest Stories

Make ethnicity pay gap reporting mandatory - PDA urges Labour government

Ethnicity Pay Gap Day 2025
gettyimages

Ethnicity Pay Gap Campaign - Employers are encouraged to pay their staff fair and equal wages regardless of race or ethnicity 

Marking Ethnicity Pay Gap Day 2025 today (January 8), the Pharmacists' Defence Association (PDA) has highlighted the need for clear and transparent pay structures.

The trade union is calling on the government to make ethnicity pay gap reporting mandatory, similar to the existing requirements for gender pay gap reporting.


The PDA BAME (Black, Asian and Minority Ethnic) Network and the wider PDA have long campaigned for the introduction of compulsory ethnicity pay gap reporting for organisations with 250 or more staff.

Despite these efforts, the previous government announced in July 2023 that it would not implement such measures.

With the new Labour government now in place, the PDA is renewing its call for the inclusion of mandatory ethnicity pay gap reporting in the proposed Employment Rights Bill.

Lola Dabiri, president of the PDA BAME Network, emphasised the importance of addressing pay disparities.

He said, “The injustice of individuals being paid less because of their ethnicity, is something that we all know happens at some employers, and pay gap reporting is the accepted way to identify such issues.”

Statistics from the Chartered Institute of Personnel and Development (CIPD) show that individuals from Black, Asian, or Ethnic Minority (BAME) backgrounds earn, on average, 89p for every £1 earned by their white counterparts.

Paul Day, PDA director of membership and communities, reaffirmed the organisation’s commitment to tackling inequality in all forms.

He encourages pharmacy employers with more than 250 staff to "monitor and report ethnicity pay gaps in advance of it becoming compulsory to do so, just as they are already required to do for gender pay gap reporting.”

He noted that larger pharmacy employers, with well-resourced HR departments, are well-positioned to undertake this task.

“Having a pay gap does not necessarily mean it has been deliberately created, but unless the workforce’s pay is monitored for the possibility it may exist, then any such gaps will continue unchecked,” Day stated.

“Even if these larger employers choose not to report publicly on ethnicity pay gaps before it becomes a requirement, they could still commence the necessary data collection and analysis now which would inform them about the issue and allow them to begin to fix things sooner,” he added.

The PDA has four Equality, Diversity, and Inclusion (EDI) Networks that provide a platform for members to work together to address discrimination and promote fair and equal wages.

The PDA's EDI Networks include the PDA BAME Network, the PDA LGBT+ (Lesbian, Gay, Bisexual and Transgender pharmacists) Network, the PDA Ability (disabled pharmacists) Network, and the PDA NAWP (National Association of Women Pharmacists) Network.

The Ethnicity Pay Gap campaign is hosting its second summit on 7 February 2025 in association with the Fawcett Society, of which the PDA NAWP Network is a member.

 

 

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less